Possible adverse effects of phenytoin given transplacentally on the fetal growth. II. Possible adverse effects on the fetal growth.:II. Possible Adverse Effects on the Fetal Growth
スポンサーリンク
概要
- 論文の詳細を見る
This study was undertaken to examine the transplacental transmission of phenytoin and its possible adverse effects on the fetal growth. When pregnant mice were fed with the chow containing various doses of PHT from 14 days before mating until the 18th day of gestation and then they were sacrificed, PHT concentrations in the fetal brain, liver, kidney and amniotic fluid increased steadily with each increment of mate rnal serum concentration and correlated well with maternal serum PHT. The abortion ratein the experimental groups increased steadily with each increment of PHT dosage. The body length, bodyweight, and contents of DNA and RNA in the brain of experimental groups were significantly lower than those in the controls. The incidence of cleft palate increased steadily in the experimental groups with each increment of PHT dosage.
- 一般社団法人 日本小児神経学会の論文
一般社団法人 日本小児神経学会 | 論文
- Levetiracetamが著効したSTXBP1遺伝子変異による大田原症候群の1例
- Cyclophosphamideが著効した抗NMDA受容体抗体脳炎の8歳男児例
- 重症心身障害医療からみた小児脳死に関する私見
- 幼児期発症の難治な多発性硬化症に対しcyclophosphamideパルス療法が有効であった1例
- Duchenne型筋ジストロフィー児への病気の説明に関する調査